IFC, EIB Group and European Commission Back Biovac to Build Africa’s First End-To-End Multi-Vaccine Manufacturing Site, Advancing Vaccine Self-Reliance
Biovac, a leading African vaccine manufacturer, has secured a major financing package from the International Finance Corporation (IFC), the EIB Group, and the European Commission to build Africa’s first end-to-end multi-vaccine manufacturing facility. The project will increase access to life-saving vaccines, strengthen the continent’s capacity to prepare for future pandemics, and advance Africa’s long-term health resilience.
Photo courtesy of Mufid Majnun.
Source: IFC (link opens in a new window)
- Categories
- Health Care, Investing
